Rapid acting insulin:
Global Rapid Acting Insulin Market Research Report
... Highlights Rapid Acting Insulin Market Outlook 2022-2027: According to the latest report by IMARC Group, titled "Rapid Acting Insulin Market: Global Industry Trends, Share, Size, ...
14
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
... diabetes. Insulin remains the most potent medication available to treat diabetes, and arguably to prevent diabetic ...using insulin much sooner in the course of ...that insulin may actually be ...
8
Global Rapid Acting Insulin Market Research and Upcoming Forecast Report
... Highlights Rapid Acting Insulin Market Outlook 2026: According to the latest report by IMARC Group, titled “Rapid Acting Insulin Market: Global Industry Trends, Share, Size, ...
11
Stability and Performance of Rapid-Acting Insulin Analogs Used for Continuous Subcutaneous Insulin Infusion: A Systematic Review
... with insulin lispro and insulin ...that insulin aspart has the lowest risk of isoelectric precipitation and, accordingly, less tendency to catheter occlusion compared with regular insulin, ...
12
Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population
... basal insulin analogs in T1DM adult population in terms of significant glycemic control with a lower risk of hypoglycemia, nocturnal hypoglycemia, dose requirement and higher flexibility [12 – ...mealtime ...
7
Efficacy and safety of rapid acting insulin analogs in special populations with type 1 diabetes or gestational diabetes : Systematic Review and Meta Analysis
... CONCLUSIONS Rapid-acting insulin analogs appear to be safe and effective in these three special populations of people with ...of insulin aspart in clinical development (faster aspart) over ...
28
Large pre and postexercise rapid acting insulin reductions preserve glycemia and prevent early but not late onset hypoglycemia in patients with type 1 diabetes
... cise rapid-acting insulin reductions may differ with patient age, fitness, and glyce- mic ...postexercise rapid-acting insulin dose re- ductions after running exercise in patients ...
9
Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial
... pre-exercise rapid-acting insulin dose to prevent exercise- induced hypoglycaemia, and the metabolic implications of this are well known ...post-exercise rapid-acting insulin ...
9
Metabolic implications when employing heavy pre and post exercise rapid acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial
... pre-exercise rapid-acting insulin dose to prevent exercise- induced hypoglycaemia, and the metabolic implications of this are well known ...post-exercise rapid-acting insulin ...
10
Mixing Insulin Glargine With Rapid-Acting Insulin: A Review of the Literature
... The pharmacokinetic study by Cengiz et al. 5 reported sig- nificant changes in peak effects of insulin action, maximum insulin concentrations, and time to peak concentrations for lispro when mixed with ...
6
Insulin glulisine (GLU) is a rapid-acting insulin analog. Original Article
... This study has several limitations. The impossibility of blinding of the study insulins due to reasons of quality as- surance is a major one. Unconscious preferences for either a new insulin or the insulin ...
8
PHARMACOKINETICS OF THE RAPID-ACTING INSULIN ANALOG, INSULIN ASPART, IN RATS, DOGS, AND PIGS, AND PHARMACODYNAMICS OF INSULIN ASPART IN PIGS
... rapid absorption rate, but the C max may also have been affected by a smaller steady-state volume of distribution for IA compared with HI. Multiple s.c. dosing of IA and HI in rats and dogs had no apparent effect ...
6
Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine
... of insulin treatments for T2DM have been ...basal insulin analogs (administered alone) are more effective than PMX analogs in lowering fasting glu- cose, PMX is more effective than long-acting basal ...
10
Endocrine Disorders. Diabetes Meds Objectives. Diabetes Type 1 and Type 2. Insulin Dynamics. Insulin is all about timing! Rapid acting insulin O P D
... Twice daily dosing with a combination of rapid and intermediate acting insulin (spit/mixed therapy) Diabetes Control and Complications.. Trial (DCCT) : better control was poss[r] ...
10
A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes
... calculate insulin dosages accurately based on insulin:carbohydrate ratio and insulin sensitivity factor only, with no reiteration of previously taught ...
9
Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
... various insulin in- jections on their own during the follow-up period, we have not analyzed the possible role of dose ...various insulin preparations that had been marketed on different ...
8
Insulin aspart is a rapid-acting human
... of rapid-acting insulin analogues in children and adoles- cents are only available for insulin ...years. Insulin aspart was rapidly absorbed and elimi- ...of insulin aspart was ...
6
Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
... human insulin, each unit of IDeg solution contains 6 nmol of ...with rapid acting insulin aspart (IAsp), which is referred to as IDegAsp or Degludec ...basal insulin coverage, while ...
14
CiteSeerX — Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth With Type 1 Diabetes Receiving Insulin Pump Therapy
... baseline or mean plasma glucose values during the euglycemic clamp studies, both within and between groups (Table 1). As shown in Fig. 1, GIR curves for aspart and lispro were nearly identical in both day 1 and day 4 ...
5
Use of Insulin Aspart, a Fast-Acting Insulin Analog, as the Mealtime Insulin in the Management of Patients With Type 1 Diabetes
... The rapid-acting insulin analogs have been designed as mealtime insulins and are currently best suited to control the rapid rise in post- prandial blood ...mealtime insulin in a ...
6